Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease

Pediatr Radiol. 2007 Jul;37(7):666-73. doi: 10.1007/s00247-007-0498-x. Epub 2007 May 31.

Abstract

Background: In patients with Kawasaki disease (KD) serial evaluation of the distribution and size of coronary artery aneurysms (CAA) is necessary for risk stratification and therapeutic management.

Objective: To apply whole-heart coronary MR angiography (CMRA) and black-blood coronary vessel wall imaging in children with KD.

Materials and methods: Six children (mean age 4.6 years, range 2.5-7.8 years) with KD underwent CMRA using a free-breathing, T2-prepared, three-dimensional steady-state free-precession (3D-SSFP), whole-heart approach with navigator gating and tracking. Vessel walls were imaged with an ECG-triggered and navigator-gated double inversion recovery (DIR) black-blood segmented turbo spin-echo sequence.

Results: There was complete agreement between CMRA and conventional angiography (n=6) in the detection of CAA (n=15). Excellent agreement was found between the two techniques in determining the maximal diameter (mean difference 0.2+/-0.7 mm), length (mean difference 0.1+/-0.8 mm) and distance from the ostium (mean difference -0.8+/-2.1 mm) of the CAAs. In all subjects with a CAA, abnormally thickened vessel walls were found (2.5+/-0.5 mm).

Conclusions: CMRA accurately defines CAA in free-breathing sedated children with KD using the whole-heart approach and detects abnormally thickened vessel walls. This technique may reduce the need for serial X-ray coronary angiography, and improve risk stratification and monitoring of therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Child, Preschool
  • Coronary Aneurysm / diagnosis*
  • Coronary Aneurysm / pathology
  • Coronary Angiography*
  • Echocardiography
  • Female
  • Humans
  • Image Interpretation, Computer-Assisted
  • Imaging, Three-Dimensional
  • Magnetic Resonance Angiography*
  • Male
  • Mucocutaneous Lymph Node Syndrome / diagnosis*
  • Mucocutaneous Lymph Node Syndrome / pathology
  • Reproducibility of Results